English
简体中文
Total: £ 56.28
Published Date: 2025-02-17 | Pages: 90 | Tables: 96 | Pharma & Healthcare
The global market for ADCC Enhanced Antibody was valued at US$ 12300 million in the year 2024 and is projected to reach a revised size of US$ 17190 million by 2031, growing at a CAGR of 4.9% during the forecast period.
ADCC enhanced antibody refers to an antibody that enhances antibody-dependent cell-mediated cytotoxic effects (ADCC) by modifying or optimizing the Fc segment of the antibody to improve its affinity with the surface of immune cells FcγR. This enhanced ADCC effect allows immune cells to more effectively recognize and kill target cells labeled by antibodies, such as tumor cells or virus-infected cells, thereby enhancing the therapeutic effectiveness of antibody drugs.
North American market for ADCC Enhanced Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for ADCC Enhanced Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of ADCC Enhanced Antibody include MacroGenics, Roche Holding AG, Novartis AG, C.H. Boehringer Sohn, Puma Biotechnology, Pfizer, Daiichi Sankyo, Takeda Pharmaceutical, Jazz Pharmaceuticals, Merus NV, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ADCC Enhanced Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADCC Enhanced Antibody.
The ADCC Enhanced Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global ADCC Enhanced Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ADCC Enhanced Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
MacroGenics
Roche Holding AG
Novartis AG
C.H. Boehringer Sohn
Puma Biotechnology
Pfizer
Daiichi Sankyo
Takeda Pharmaceutical
Jazz Pharmaceuticals
Merus NV
Hengrui Medicine
Sansheng Guojian
RemeGen Biopharma
Dizal (Jiangsu) Pharmaceutical
Segment by Type
Monospecific Antibody
Polyspecific Antibody
Fc Fusion Protein
Antibody Fusion Protein
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of ADCC Enhanced Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of ADCC Enhanced Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 ADCC Enhanced Antibody Market Overview
1.1 Product Definition
1.2 ADCC Enhanced Antibody by Type
1.2.1 Global ADCC Enhanced Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monospecific Antibody
1.2.3 Polyspecific Antibody
1.2.4 Fc Fusion Protein
1.2.5 Antibody Fusion Protein
1.3 ADCC Enhanced Antibody by Application
1.3.1 Global ADCC Enhanced Antibody Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global ADCC Enhanced Antibody Market Size Estimates and Forecasts
1.4.1 Global ADCC Enhanced Antibody Revenue 2020-2031
1.4.2 Global ADCC Enhanced Antibody Sales 2020-2031
1.4.3 Global ADCC Enhanced Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 ADCC Enhanced Antibody Market Competition by Manufacturers
2.1 Global ADCC Enhanced Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global ADCC Enhanced Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global ADCC Enhanced Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of ADCC Enhanced Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of ADCC Enhanced Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of ADCC Enhanced Antibody, Product Type & Application
2.7 Global Key Manufacturers of ADCC Enhanced Antibody, Date of Enter into This Industry
2.8 Global ADCC Enhanced Antibody Market Competitive Situation and Trends
2.8.1 Global ADCC Enhanced Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest ADCC Enhanced Antibody Players Market Share by Revenue
2.8.3 Global ADCC Enhanced Antibody Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global ADCC Enhanced Antibody Market Scenario by Region
3.1 Global ADCC Enhanced Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global ADCC Enhanced Antibody Sales by Region: 2020-2031
3.2.1 Global ADCC Enhanced Antibody Sales by Region: 2020-2025
3.2.2 Global ADCC Enhanced Antibody Sales by Region: 2026-2031
3.3 Global ADCC Enhanced Antibody Revenue by Region: 2020-2031
3.3.1 Global ADCC Enhanced Antibody Revenue by Region: 2020-2025
3.3.2 Global ADCC Enhanced Antibody Revenue by Region: 2026-2031
3.4 North America ADCC Enhanced Antibody Market Facts & Figures by Country
3.4.1 North America ADCC Enhanced Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America ADCC Enhanced Antibody Sales by Country (2020-2031)
3.4.3 North America ADCC Enhanced Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe ADCC Enhanced Antibody Market Facts & Figures by Country
3.5.1 Europe ADCC Enhanced Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe ADCC Enhanced Antibody Sales by Country (2020-2031)
3.5.3 Europe ADCC Enhanced Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ADCC Enhanced Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific ADCC Enhanced Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific ADCC Enhanced Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific ADCC Enhanced Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America ADCC Enhanced Antibody Market Facts & Figures by Country
3.7.1 Latin America ADCC Enhanced Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America ADCC Enhanced Antibody Sales by Country (2020-2031)
3.7.3 Latin America ADCC Enhanced Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa ADCC Enhanced Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa ADCC Enhanced Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa ADCC Enhanced Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa ADCC Enhanced Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global ADCC Enhanced Antibody Sales by Type (2020-2031)
4.1.1 Global ADCC Enhanced Antibody Sales by Type (2020-2025)
4.1.2 Global ADCC Enhanced Antibody Sales by Type (2026-2031)
4.1.3 Global ADCC Enhanced Antibody Sales Market Share by Type (2020-2031)
4.2 Global ADCC Enhanced Antibody Revenue by Type (2020-2031)
4.2.1 Global ADCC Enhanced Antibody Revenue by Type (2020-2025)
4.2.2 Global ADCC Enhanced Antibody Revenue by Type (2026-2031)
4.2.3 Global ADCC Enhanced Antibody Revenue Market Share by Type (2020-2031)
4.3 Global ADCC Enhanced Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global ADCC Enhanced Antibody Sales by Application (2020-2031)
5.1.1 Global ADCC Enhanced Antibody Sales by Application (2020-2025)
5.1.2 Global ADCC Enhanced Antibody Sales by Application (2026-2031)
5.1.3 Global ADCC Enhanced Antibody Sales Market Share by Application (2020-2031)
5.2 Global ADCC Enhanced Antibody Revenue by Application (2020-2031)
5.2.1 Global ADCC Enhanced Antibody Revenue by Application (2020-2025)
5.2.2 Global ADCC Enhanced Antibody Revenue by Application (2026-2031)
5.2.3 Global ADCC Enhanced Antibody Revenue Market Share by Application (2020-2031)
5.3 Global ADCC Enhanced Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 MacroGenics
6.1.1 MacroGenics Company Information
6.1.2 MacroGenics Description and Business Overview
6.1.3 MacroGenics ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 MacroGenics ADCC Enhanced Antibody Product Portfolio
6.1.5 MacroGenics Recent Developments/Updates
6.2 Roche Holding AG
6.2.1 Roche Holding AG Company Information
6.2.2 Roche Holding AG Description and Business Overview
6.2.3 Roche Holding AG ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Roche Holding AG ADCC Enhanced Antibody Product Portfolio
6.2.5 Roche Holding AG Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Company Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis AG ADCC Enhanced Antibody Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 C.H. Boehringer Sohn
6.4.1 C.H. Boehringer Sohn Company Information
6.4.2 C.H. Boehringer Sohn Description and Business Overview
6.4.3 C.H. Boehringer Sohn ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 C.H. Boehringer Sohn ADCC Enhanced Antibody Product Portfolio
6.4.5 C.H. Boehringer Sohn Recent Developments/Updates
6.5 Puma Biotechnology
6.5.1 Puma Biotechnology Company Information
6.5.2 Puma Biotechnology Description and Business Overview
6.5.3 Puma Biotechnology ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Puma Biotechnology ADCC Enhanced Antibody Product Portfolio
6.5.5 Puma Biotechnology Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer ADCC Enhanced Antibody Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Daiichi Sankyo
6.7.1 Daiichi Sankyo Company Information
6.7.2 Daiichi Sankyo Description and Business Overview
6.7.3 Daiichi Sankyo ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Daiichi Sankyo ADCC Enhanced Antibody Product Portfolio
6.7.5 Daiichi Sankyo Recent Developments/Updates
6.8 Takeda Pharmaceutical
6.8.1 Takeda Pharmaceutical Company Information
6.8.2 Takeda Pharmaceutical Description and Business Overview
6.8.3 Takeda Pharmaceutical ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Takeda Pharmaceutical ADCC Enhanced Antibody Product Portfolio
6.8.5 Takeda Pharmaceutical Recent Developments/Updates
6.9 Jazz Pharmaceuticals
6.9.1 Jazz Pharmaceuticals Company Information
6.9.2 Jazz Pharmaceuticals Description and Business Overview
6.9.3 Jazz Pharmaceuticals ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jazz Pharmaceuticals ADCC Enhanced Antibody Product Portfolio
6.9.5 Jazz Pharmaceuticals Recent Developments/Updates
6.10 Merus NV
6.10.1 Merus NV Company Information
6.10.2 Merus NV Description and Business Overview
6.10.3 Merus NV ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Merus NV ADCC Enhanced Antibody Product Portfolio
6.10.5 Merus NV Recent Developments/Updates
6.11 Hengrui Medicine
6.11.1 Hengrui Medicine Company Information
6.11.2 Hengrui Medicine Description and Business Overview
6.11.3 Hengrui Medicine ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hengrui Medicine ADCC Enhanced Antibody Product Portfolio
6.11.5 Hengrui Medicine Recent Developments/Updates
6.12 Sansheng Guojian
6.12.1 Sansheng Guojian Company Information
6.12.2 Sansheng Guojian Description and Business Overview
6.12.3 Sansheng Guojian ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sansheng Guojian ADCC Enhanced Antibody Product Portfolio
6.12.5 Sansheng Guojian Recent Developments/Updates
6.13 RemeGen Biopharma
6.13.1 RemeGen Biopharma Company Information
6.13.2 RemeGen Biopharma Description and Business Overview
6.13.3 RemeGen Biopharma ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 RemeGen Biopharma ADCC Enhanced Antibody Product Portfolio
6.13.5 RemeGen Biopharma Recent Developments/Updates
6.14 Dizal (Jiangsu) Pharmaceutical
6.14.1 Dizal (Jiangsu) Pharmaceutical Company Information
6.14.2 Dizal (Jiangsu) Pharmaceutical Description and Business Overview
6.14.3 Dizal (Jiangsu) Pharmaceutical ADCC Enhanced Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Dizal (Jiangsu) Pharmaceutical ADCC Enhanced Antibody Product Portfolio
6.14.5 Dizal (Jiangsu) Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ADCC Enhanced Antibody Industry Chain Analysis
7.2 ADCC Enhanced Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ADCC Enhanced Antibody Production Mode & Process Analysis
7.4 ADCC Enhanced Antibody Sales and Marketing
7.4.1 ADCC Enhanced Antibody Sales Channels
7.4.2 ADCC Enhanced Antibody Distributors
7.5 ADCC Enhanced Antibody Customer Analysis
8 ADCC Enhanced Antibody Market Dynamics
8.1 ADCC Enhanced Antibody Industry Trends
8.2 ADCC Enhanced Antibody Market Drivers
8.3 ADCC Enhanced Antibody Market Challenges
8.4 ADCC Enhanced Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global ADCC Enhanced Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global ADCC Enhanced Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global ADCC Enhanced Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global ADCC Enhanced Antibody Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global ADCC Enhanced Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global ADCC Enhanced Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global ADCC Enhanced Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market ADCC Enhanced Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of ADCC Enhanced Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of ADCC Enhanced Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of ADCC Enhanced Antibody, Product Type & Application
Table 12. Global Key Manufacturers of ADCC Enhanced Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global ADCC Enhanced Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADCC Enhanced Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global ADCC Enhanced Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global ADCC Enhanced Antibody Sales by Region (2020-2025) & (K Units)
Table 18. Global ADCC Enhanced Antibody Sales Market Share by Region (2020-2025)
Table 19. Global ADCC Enhanced Antibody Sales by Region (2026-2031) & (K Units)
Table 20. Global ADCC Enhanced Antibody Sales Market Share by Region (2026-2031)
Table 21. Global ADCC Enhanced Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global ADCC Enhanced Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global ADCC Enhanced Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global ADCC Enhanced Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America ADCC Enhanced Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America ADCC Enhanced Antibody Sales by Country (2020-2025) & (K Units)
Table 27. North America ADCC Enhanced Antibody Sales by Country (2026-2031) & (K Units)
Table 28. North America ADCC Enhanced Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America ADCC Enhanced Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe ADCC Enhanced Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe ADCC Enhanced Antibody Sales by Country (2020-2025) & (K Units)
Table 32. Europe ADCC Enhanced Antibody Sales by Country (2026-2031) & (K Units)
Table 33. Europe ADCC Enhanced Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe ADCC Enhanced Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific ADCC Enhanced Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific ADCC Enhanced Antibody Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific ADCC Enhanced Antibody Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific ADCC Enhanced Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific ADCC Enhanced Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America ADCC Enhanced Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America ADCC Enhanced Antibody Sales by Country (2020-2025) & (K Units)
Table 42. Latin America ADCC Enhanced Antibody Sales by Country (2026-2031) & (K Units)
Table 43. Latin America ADCC Enhanced Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America ADCC Enhanced Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa ADCC Enhanced Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa ADCC Enhanced Antibody Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa ADCC Enhanced Antibody Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa ADCC Enhanced Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa ADCC Enhanced Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global ADCC Enhanced Antibody Sales (K Units) by Type (2020-2025)
Table 51. Global ADCC Enhanced Antibody Sales (K Units) by Type (2026-2031)
Table 52. Global ADCC Enhanced Antibody Sales Market Share by Type (2020-2025)
Table 53. Global ADCC Enhanced Antibody Sales Market Share by Type (2026-2031)
Table 54. Global ADCC Enhanced Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global ADCC Enhanced Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global ADCC Enhanced Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global ADCC Enhanced Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global ADCC Enhanced Antibody Price (US$/Unit) by Type (2020-2025)
Table 59. Global ADCC Enhanced Antibody Price (US$/Unit) by Type (2026-2031)
Table 60. Global ADCC Enhanced Antibody Sales (K Units) by Application (2020-2025)
Table 61. Global ADCC Enhanced Antibody Sales (K Units) by Application (2026-2031)
Table 62. Global ADCC Enhanced Antibody Sales Market Share by Application (2020-2025)
Table 63. Global ADCC Enhanced Antibody Sales Market Share by Application (2026-2031)
Table 64. Global ADCC Enhanced Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global ADCC Enhanced Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global ADCC Enhanced Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global ADCC Enhanced Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global ADCC Enhanced Antibody Price (US$/Unit) by Application (2020-2025)
Table 69. Global ADCC Enhanced Antibody Price (US$/Unit) by Application (2026-2031)
Table 70. MacroGenics Company Information
Table 71. MacroGenics Description and Business Overview
Table 72. MacroGenics ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. MacroGenics ADCC Enhanced Antibody Product
Table 74. MacroGenics Recent Developments/Updates
Table 75. Roche Holding AG Company Information
Table 76. Roche Holding AG Description and Business Overview
Table 77. Roche Holding AG ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Roche Holding AG ADCC Enhanced Antibody Product
Table 79. Roche Holding AG Recent Developments/Updates
Table 80. Novartis AG Company Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Novartis AG ADCC Enhanced Antibody Product
Table 84. Novartis AG Recent Developments/Updates
Table 85. C.H. Boehringer Sohn Company Information
Table 86. C.H. Boehringer Sohn Description and Business Overview
Table 87. C.H. Boehringer Sohn ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. C.H. Boehringer Sohn ADCC Enhanced Antibody Product
Table 89. C.H. Boehringer Sohn Recent Developments/Updates
Table 90. Puma Biotechnology Company Information
Table 91. Puma Biotechnology Description and Business Overview
Table 92. Puma Biotechnology ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Puma Biotechnology ADCC Enhanced Antibody Product
Table 94. Puma Biotechnology Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Pfizer ADCC Enhanced Antibody Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Daiichi Sankyo Company Information
Table 101. Daiichi Sankyo Description and Business Overview
Table 102. Daiichi Sankyo ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Daiichi Sankyo ADCC Enhanced Antibody Product
Table 104. Daiichi Sankyo Recent Developments/Updates
Table 105. Takeda Pharmaceutical Company Information
Table 106. Takeda Pharmaceutical Description and Business Overview
Table 107. Takeda Pharmaceutical ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Takeda Pharmaceutical ADCC Enhanced Antibody Product
Table 109. Takeda Pharmaceutical Recent Developments/Updates
Table 110. Jazz Pharmaceuticals Company Information
Table 111. Jazz Pharmaceuticals Description and Business Overview
Table 112. Jazz Pharmaceuticals ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Jazz Pharmaceuticals ADCC Enhanced Antibody Product
Table 114. Jazz Pharmaceuticals Recent Developments/Updates
Table 115. Merus NV Company Information
Table 116. Merus NV Description and Business Overview
Table 117. Merus NV ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Merus NV ADCC Enhanced Antibody Product
Table 119. Merus NV Recent Developments/Updates
Table 120. Hengrui Medicine Company Information
Table 121. Hengrui Medicine Description and Business Overview
Table 122. Hengrui Medicine ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Hengrui Medicine ADCC Enhanced Antibody Product
Table 124. Hengrui Medicine Recent Developments/Updates
Table 125. Sansheng Guojian Company Information
Table 126. Sansheng Guojian Description and Business Overview
Table 127. Sansheng Guojian ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Sansheng Guojian ADCC Enhanced Antibody Product
Table 129. Sansheng Guojian Recent Developments/Updates
Table 130. RemeGen Biopharma Company Information
Table 131. RemeGen Biopharma Description and Business Overview
Table 132. RemeGen Biopharma ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. RemeGen Biopharma ADCC Enhanced Antibody Product
Table 134. RemeGen Biopharma Recent Developments/Updates
Table 135. Dizal (Jiangsu) Pharmaceutical Company Information
Table 136. Dizal (Jiangsu) Pharmaceutical Description and Business Overview
Table 137. Dizal (Jiangsu) Pharmaceutical ADCC Enhanced Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Dizal (Jiangsu) Pharmaceutical ADCC Enhanced Antibody Product
Table 139. Dizal (Jiangsu) Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. ADCC Enhanced Antibody Distributors List
Table 143. ADCC Enhanced Antibody Customers List
Table 144. ADCC Enhanced Antibody Market Trends
Table 145. ADCC Enhanced Antibody Market Drivers
Table 146. ADCC Enhanced Antibody Market Challenges
Table 147. ADCC Enhanced Antibody Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of ADCC Enhanced Antibody
Figure 2. Global ADCC Enhanced Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global ADCC Enhanced Antibody Market Share by Type: 2024 & 2031
Figure 4. Monospecific Antibody Product Picture
Figure 5. Polyspecific Antibody Product Picture
Figure 6. Fc Fusion Protein Product Picture
Figure 7. Antibody Fusion Protein Product Picture
Figure 8. Global ADCC Enhanced Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global ADCC Enhanced Antibody Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global ADCC Enhanced Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global ADCC Enhanced Antibody Market Size (2020-2031) & (US$ Million)
Figure 15. Global ADCC Enhanced Antibody Sales (2020-2031) & (K Units)
Figure 16. Global ADCC Enhanced Antibody Average Price (US$/Unit) & (2020-2031)
Figure 17. ADCC Enhanced Antibody Report Years Considered
Figure 18. ADCC Enhanced Antibody Sales Share by Manufacturers in 2024
Figure 19. Global ADCC Enhanced Antibody Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest ADCC Enhanced Antibody Players: Market Share by Revenue in ADCC Enhanced Antibody in 2024
Figure 21. ADCC Enhanced Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global ADCC Enhanced Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America ADCC Enhanced Antibody Sales Market Share by Country (2020-2031)
Figure 24. North America ADCC Enhanced Antibody Revenue Market Share by Country (2020-2031)
Figure 25. United States ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe ADCC Enhanced Antibody Sales Market Share by Country (2020-2031)
Figure 28. Europe ADCC Enhanced Antibody Revenue Market Share by Country (2020-2031)
Figure 29. Germany ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific ADCC Enhanced Antibody Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific ADCC Enhanced Antibody Revenue Market Share by Region (2020-2031)
Figure 36. China ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America ADCC Enhanced Antibody Sales Market Share by Country (2020-2031)
Figure 44. Latin America ADCC Enhanced Antibody Revenue Market Share by Country (2020-2031)
Figure 45. Mexico ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa ADCC Enhanced Antibody Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa ADCC Enhanced Antibody Revenue Market Share by Country (2020-2031)
Figure 51. Turkey ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE ADCC Enhanced Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of ADCC Enhanced Antibody by Type (2020-2031)
Figure 55. Global Revenue Market Share of ADCC Enhanced Antibody by Type (2020-2031)
Figure 56. Global ADCC Enhanced Antibody Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of ADCC Enhanced Antibody by Application (2020-2031)
Figure 58. Global Revenue Market Share of ADCC Enhanced Antibody by Application (2020-2031)
Figure 59. Global ADCC Enhanced Antibody Price (US$/Unit) by Application (2020-2031)
Figure 60. ADCC Enhanced Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
